Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -16.46 is 96% above its 5-year average of -404.68, near the high end of its 5-year range (-1244.28–-16.46).
87.56% above its 12-month average of -132.36.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.76.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:06:29.295Z. Historical observations retain their original dates. Historical series through 2008-11-12.
EARNINGS PER SHARE (EPS)
-16.46
EARNINGS PER SHARE (EPS) AVG TTM
-132.36
EARNINGS PER SHARE (EPS) AVG 3Y
-129.45
EARNINGS PER SHARE (EPS) AVG 5Y
-404.68
EARNINGS PER SHARE (EPS) AVG 10Y
-9720.61
EARNINGS PER SHARE (EPS) AVG 15Y
-2989.10
EARNINGS PER SHARE (EPS) AVG 20Y
-5462.80
CURRENT VS TTM AVG
+87.56%
CURRENT VS 3Y AVG
+87.28%
CURRENT VS 5Y AVG
+95.93%
CURRENT VS 10Y AVG
+99.83%
CURRENT VS 15Y AVG
+99.45%
CURRENT VS 20Y AVG
+99.70%
Enveric Biosciences, Inc.
Market Cap
$6.49M
Earnings Per Share (EPS)
-16.46
TTM Avg
-132.36
3Y Avg
-129.45
5Y Avg
-404.68
Market Cap
$6.57M
Earnings Per Share (EPS)
-2.52
TTM Avg
-4.28
3Y Avg
-38.17
5Y Avg
-84.63
Market Cap
$6.80M
Earnings Per Share (EPS)
-7.60
TTM Avg
-3746.91
3Y Avg
-66167.96
5Y Avg
-82548.30
Market Cap
$6.21M
Earnings Per Share (EPS)
-1.26
TTM Avg
-1.73
3Y Avg
-1.08
5Y Avg
-0.87
Market Cap
$6.82M
Earnings Per Share (EPS)
-16.00
TTM Avg
-9.75
3Y Avg
-5.91
5Y Avg
-4.74
Market Cap
$6.13M
Earnings Per Share (EPS)
-4.57
TTM Avg
-13.10
3Y Avg
-16.05
5Y Avg
-14.80
Market Cap
$6.08M
Earnings Per Share (EPS)
537.52
TTM Avg
197.33
3Y Avg
123.75
5Y Avg
69.48
Market Cap
$5.98M
Earnings Per Share (EPS)
-2.92
TTM Avg
-6.51
3Y Avg
-19.53
5Y Avg
-13.36
Market Cap
$7.07M
Earnings Per Share (EPS)
-26.72
TTM Avg
-36.23
3Y Avg
-30.51
5Y Avg
-16.78
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | $6.49M | -16.46 | -132.36 | -129.45 | -404.68 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.57M | -2.52 | -4.28 | -38.17 | -84.63 |
| Aclarion, Inc. (ACON)vs › | $6.80M | -7.60 | -3746.91 | -66167.96 | -82548.30 |
| Biomerica, Inc. (BMRA)vs › | $6.21M | -1.26 | -1.73 | -1.08 | -0.87 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.82M | -16.00 | -9.75 | -5.91 | -4.74 |
| Femasys Inc. (FEMY)vs › | $6.13M | -4.57 | -13.10 | -16.05 | -14.80 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.08M | 537.52 | 197.33 | 123.75 | 69.48 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.98M | -2.92 | -6.51 | -19.53 | -13.36 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | -26.72 | -36.23 | -30.51 | -16.78 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.17M | -7.38 | -1.62 | -0.82 | -0.82 |
Trailing EPS (TTM)
$-16.46
Forward EPS (Est.)
$-315.00
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -36.24 |
| 2024-12-31 | -228.48 |
| 2023-12-31 | -97.08 |
| 2022-12-31 | -156.00 |
| 2021-12-31 | -1244.28 |
| 2020-12-31 | -666.00 |
| 2019-12-31 | -2543.88 |
| 2018-12-31 | -42616.68 |
| 2017-12-31 | -36347.76 |
| 2016-12-31 | -12770.04 |
| 2015-12-31 | -10220.28 |
| 2014-12-31 | -2307.00 |
| 2013-12-31 | -14.16 |
| 2012-12-31 | -2156.64 |
| 2011-12-31 | -2923.80 |
| 2010-12-31 | -6483.48 |
| 2009-12-31 | -9623.64 |
| 2008-12-31 | -23611.44 |
| 2007-12-31 | 132696.00 |
| 2006-12-31 | -76936.56 |
| 2005-12-31 | -17785.08 |
| 2004-12-31 | -35658.12 |
| 2003-12-31 | -112178.04 |
| 2002-12-31 | 4141.56 |
| 2001-12-31 | -54363.84 |
| 2000-12-31 | 86494.92 |
| 1999-12-31 | 81875.04 |
| 1998-12-31 | -2242088.16 |
| 1997-12-31 | -2359910.52 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T14:06:29.295Z. Historical observations retain their original dates. Historical series through 2008-11-12.
